Personalised medicine could curb healthcare costs
You must be signed in to read this analysis
In this article
- Anti-retroviral treatments
- Cancer
- Renewed opportunities
- Challenges ahead
- Fragmentation
- System interoperability
- Cost-benefit
- Regulatory
- Lack of coordination
- Liability
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
_350.jpg "A technician works in a DNA sequencing laboratory (REUTERS/Larry Downing)")